en

PRODUCT DETAIL

RAYVOW 200 mg filmom obalené tablety

Code 2124E
MA number EU/1/21/1587/025
Product Form: tbl flm 16x1x200 mg (blis.PCTFE/PVC/Al - jednotk.bal.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 07 - ANALGETICA, ANTIPYRETICA
ATC:
N NERVOUS SYSTEM
N02 ANALGESICS
N02C ANTIMIGRAINE PREPARATIONS
N02CC Selective serotonin (5-HT1) agonists
N02CC08 Lasmiditan
Shelf life: 24
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 17.08.2022
Validity: 17.08.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 30.09.2022
eu-flag.png sk-flag.png